Hikal Ltd. Boards Meeting Scheduled to Approve Unaudited Financial Results for Quarter Ending June 30, 2026
Hikal Ltd. has scheduled a Board Meeting of its Directors to consider and approve the Standalone and Consolidated Unaudited Financial Results for the quarter that ended on June 30, 2026.The meeting is set to take place on Thursday, August 06, 2026. The purpose of the board meeting includes taking the results on record.
HIKAL Stock Price Movement
Shares of Hikal Limited shed 1.58% in trading, closing today at ₹216.99 after a steady session in the pharmaceutical sector. The equity saw total traded volume stand at 123,310 shares, having previously tested an intraday high of ₹222.88.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.